Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
70.8 ILa | +4.73% | +13.46% | +111.34% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Abraham Dreazen
CEO | Chief Executive Officer | 40 | 20-08-11 |
Ishai Gandelsman
DFI | Director of Finance/CFO | 61 | 22-07-09 |
General Counsel | 53 | 20-08-11 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 93-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yaacov Elinav
BRD | Director/Board Member | 79 | 20-08-11 |
Israel Makov
CHM | Chairman | 85 | 11-11-20 |
Ron Grupel
BRD | Director/Board Member | 73 | 14-10-12 |
Jakob Ripshtein
BRD | Director/Board Member | 57 | 20-08-11 |
Orna Dreazen
BRD | Director/Board Member | 69 | 20-08-11 |
Director/Board Member | 59 | 20-08-11 | |
Director/Board Member | 72 | 20-08-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 33,268,639 | 5,146,509 ( 15.47 %) | 0 | 15.47 % |
Company contact information
NEXTAGE Therapeutics Ltd.
Einstein Street, Building 13B Weizmann Science Park
7403617, Ness Ziona
+
http://www.nxtg.co.ilSector
1st Jan change | Capi. | |
---|---|---|
+111.34% | 6.06M | |
-38.56% | 8.39B | |
+0.18% | 3.32B | |
+9.29% | 2.48B | |
-18.21% | 2.06B | |
-24.57% | 1.59B | |
+32.37% | 1.15B | |
-7.64% | 704M | |
+8.42% | 678M | |
-29.59% | 508M |
- Stock Market
- Equities
- NXTG Stock
- Company Nextage Therapeutics Ltd